Healthcare


 Penny Healthcare Stock Aeterna Zentaris (TSX:AEZS) Up 200%

Penny Healthcare Stock Aeterna Zentaris (TSX:AEZS) Up 200%

February 09, 2021 09:15 AM EST| By Hina Chowdhary

Summary Stocks of Aeterna Zentaris Inc zoomed multiple folds higher on Monday, with nearly 200 per cent. The biopharma stock also achieved its 52-week high of C$4.63 yesterday, with a one-year return of 187 per cent. The FDA-approved medical t.....

 Zosano Pharma (ZSAN) Stock Up 75%: Should You Buy & Hold It?

Zosano Pharma (ZSAN) Stock Up 75%: Should You Buy & Hold It?

February 09, 2021 03:35 AM EST| By Team Kalkine Media

Summary Stocks of pharmaceutical company Zosano Pharma Corp (NASDAQ:ZSAN, ZSAN:US) shot up by over 75 per cent on Monday, February 8. While there were no clear business or corporate news from the company, some media outlets reported on Monday t.....

 Ocugen (NASDAQ: OCGN) Stocks Skyrocket Over 180%

Ocugen (NASDAQ: OCGN) Stocks Skyrocket Over 180%

February 08, 2021 12:09 PM EST| By Hina Chowdhary

Summary Ocugen plans to raise US$23 million from a direct stock offering to institutional investors this week. The company plans to launch the Covid vaccine CovaxinTM in the US market this year. In the last three months, its stock value rose b.....

 Well Health (TSX:WELL) & CRH Stocks Skyrocket On Acquisition News

Well Health (TSX:WELL) & CRH Stocks Skyrocket On Acquisition News

February 08, 2021 09:41 AM EST| By Hina Chowdhary

Summary Canadian health care service provider WELL Health Technologies Corp has announced its plans to acquire medical equipment maker CRH Medical Corp on Monday, February 8. While WELL Health’s stocks were up over 21 per cent on Monday m.....

 Opsens (TSX:OPS): A Penny Medical Stock Worth Exploring!

Opsens (TSX:OPS): A Penny Medical Stock Worth Exploring!

February 08, 2021 07:43 AM EST| By Kunal Sawhney

Summary Canadian medtech company Opsens announced a bought deal worth C$ 25 million last week. The company’s stock has bounced back from its 52-week low by 361 per cent. The medical stock has swelled over 35 per cent this year, with a on.....

 Zomedica (NYSE:ZOM) Up 27%: Should You Buy This Growth Stock?

Zomedica (NYSE:ZOM) Up 27%: Should You Buy This Growth Stock?

February 07, 2021 12:02 AM EST| By Ipsita Sarkar

American veterinary pharmaceutical company Zomedica Corp’s (NYSE: ZOM) recent success on the stock market has drawn investors’ attention, but is it a winning stock you are looking for in 2021? ZOM stock’s amazing run this week ha.....

 Ocugen (NASDAQ:OCGN) Stocks Are Flying: Time To Add In Portfolio?

Ocugen (NASDAQ:OCGN) Stocks Are Flying: Time To Add In Portfolio?

February 06, 2021 04:53 AM EST| By Kunal Sawhney

Summary Ocugen’s stocks climbed more than 61 per cent on Friday after healthcare analysts bet on its collaboration with Bharat Biotech to manufacture COVID vaccine COVAXIN™. The biopharma stock has zoomed as much as 2988 per cent fr.....

 T2 Biosystems (TTOO) Stocks Soar On 99.99% Efficacy Of COVID Test Panel

T2 Biosystems (TTOO) Stocks Soar On 99.99% Efficacy Of COVID Test Panel

February 05, 2021 12:03 PM EST| By Hina Chowdhary

Summary T2 Biosystems’ coronavirus detection panel reportedly achieved an effectiveness of 99.99 per cent to spot the new mutant variants of the virus. The medical device manufacturer’s stock rocketed over 42 per cent on Friday morn.....

 Tyme (NASDAQ:TYME) Stocks Soar 94% On Patent For COVID Treatment

Tyme (NASDAQ:TYME) Stocks Soar 94% On Patent For COVID Treatment

February 04, 2021 08:10 AM EST| By Hina Chowdhary

Summary Stocks of Tyme Technologies (NASDAQ:TYME, TYME:US) skyrocketed by nearly 94 per cent on Wednesday. The biotechnology company announced receiving a patent for a coronavirus treatment using its metabolomic technology platform from the US .....

 GlaxoSmithKline & CureVac Collaborate To Develop COVID-19 Vaccines

GlaxoSmithKline & CureVac Collaborate To Develop COVID-19 Vaccines

February 03, 2021 09:27 AM EST| By Kunal Sawhney

Summary GlaxoSmithKline and CureVac announced their partnership to co-produce mRNA-based COVID-19 vaccine candidates that would combat the new coronavirus mutants. Stocks of both pharma companies started showing movement in pre-market hours. Cu.....

 Ocugen & Cassava: 2 Biotech Stocks On The Rise

Ocugen & Cassava: 2 Biotech Stocks On The Rise

February 03, 2021 06:16 AM EST| By Kunal Sawhney

Summary Ocugen’s stock soared 80 per cent on Tuesday, as the company announced its collaboration with India’s Bharat Biotech to retail and co-develop COVID-19 Vaccine COVAXIN™ in the US markets post FDA approval. Ocugen’.....

 Therma Bright & CloudMD: 2 Trending TSXV Healthcare Stocks

Therma Bright & CloudMD: 2 Trending TSXV Healthcare Stocks

January 27, 2021 11:32 AM EST| By Kunal Sawhney

Summary CloudMD’s shares climbed by 9 per cent as the company announced to buy Rxi’s pharma logistic services. Stocks of CloudMD have gained over 342 per cent in the last six months. Therma Bright’s one-year return has skyroc.....

 Novavax (NVAX) Stocks Up As Canada Agrees To Buy 76-Mn Vaccine Shots

Novavax (NVAX) Stocks Up As Canada Agrees To Buy 76-Mn Vaccine Shots

January 25, 2021 04:42 AM EST| By Team Kalkine Media

Summary Novavax has received an advance order from Canada for its COVID-19 vaccine candidate NVX-Cov2373. Its stocks climbed nearly 4 per cent on this agreement. The biotech scrips are 1532 per cent up in one year, led by the US government fund.....

 Adamis (NASDAQ:ADMP) Stocks Surge On COVID & Walgreens Developments

Adamis (NASDAQ:ADMP) Stocks Surge On COVID & Walgreens Developments

January 22, 2021 11:40 AM EST| By Kunal Sawhney

Summary Adamis stocks shot up by over 50 per cent on Friday morning, January 22. The shares had surged by about 75 per cent on Wednesday after it announced submitting an Investigational New Drug (IND) named Tempol to the FDA for a COVID-related.....

 Titan Medical & OpSens: 2 TSX-Listed Healthcare Penny Stocks To Explore

Titan Medical & OpSens: 2 TSX-Listed Healthcare Penny Stocks To Explore

January 21, 2021 08:49 AM EST| By Hina Chowdhary

Summary Titan Medical’s stock yielded 114 returns in the last one month and a part of top healthcare companies on the TSX. OpSens’ scrips are up 79 per cent in the past one month, led by the higher quarterly earnings. Both the medi.....

 Obalon (NASDAQ:OBLN) & Caladrius (CLBS): 2 Soaring Life Science Stocks

Obalon (NASDAQ:OBLN) & Caladrius (CLBS): 2 Soaring Life Science Stocks

January 21, 2021 04:27 AM EST| By Team Kalkine Media

Summary Obalon’s stock boomed over 414 per cent over its merger announcement with ReShape, its 446 million shares traded on NASDAQ. Stocks of Caladrius Bioscience skyrocketed by 77 per cent on the back of its Phase-2 trial initiation for .....

 Aclaris Therapeutics (ACRS) & Dare Bioscience: 2 Biotech Stocks To Watch

Aclaris Therapeutics (ACRS) & Dare Bioscience: 2 Biotech Stocks To Watch

January 20, 2021 11:21 AM EST| By Kunal Sawhney

Summary Aclaris’ stock added triple gains on January 19, on the back of a successful phase-2 trial of its oral inflammatory drug, ATI-450. Dare’s shares have soared by 86 per cent YTD, led by its research and development success. B.....

 Therma Bright (TSXV:THRM) Stocks Gain 78% After Improved COVID Test Results

Therma Bright (TSXV:THRM) Stocks Gain 78% After Improved COVID Test Results

January 19, 2021 04:03 AM EST| By Team Kalkine Media

Canadian medical device technology company Therma Bright Inc (TSXV:THRM) reported on Monday, January 18, that its rapid saliva antigen test for COVID-19 has delivered “improved accuracy” in the latest results. The company added that it is...

 Profound (TSX:PRN) & Bausch (TSX:BHC): 2 Healthcare Stocks On The Move

Profound (TSX:PRN) & Bausch (TSX:BHC): 2 Healthcare Stocks On The Move

January 15, 2021 09:18 AM EST| By Team Kalkine Media

Summary Stocks of Profound and Bausch have outperformed the S&P/TSX Capped Health Care Index in terms of returns in the last one month. Bausch anticipated generating a revenue of more than C$ 2.2 billion in the fourth quarter of 2020. Prof.....

 Pfizer & BioNTech Stocks Gain On Higher COVID Vaccine Target

Pfizer & BioNTech Stocks Gain On Higher COVID Vaccine Target

January 11, 2021 11:47 AM EST| By Kunal Sawhney

Pfizer Inc. and BioNTech SE increased their COVID-19 vaccine manufacturing target for the current year to 2 billion doses in the wake of higher global demands. Stocks of BioNTech (BNTX:US or NASDAQ: BNTX) and Pfizer Inc. (PFE:US or NYSE: PFE) soared...

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.